MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Horizon Pharma PLC Company Profile (NASDAQ:HZNP)

Consensus Ratings for Horizon Pharma PLC (NASDAQ:HZNP) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.77)
Consensus Price Target: $31.36 (93.01% upside)

Analysts' Ratings History for Horizon Pharma PLC (NASDAQ:HZNP)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016Goldman SachsInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Citigroup Inc.Initiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Piper JaffrayReiterated RatingOverweight$44.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016GuggenheimReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016MizuhoReiterated RatingBuy$25.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2016Brean CapitalReiterated RatingBuy$32.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016Jefferies GroupReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Morgan StanleyReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2015WallachBeth CapitalUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2015JMP SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015Leerink SwannReiterated RatingPositive$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014Avondale PartnersInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/24/2014 forward)
Earnings History for Horizon Pharma PLC (NASDAQ:HZNP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/9/2016Q116$0.30$0.34$197.73 million$204.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q415$0.62$0.63$240.92 million$244.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2015Q315$0.40$0.70$185.70 million$292.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2015Q215$0.32$0.39$156.41 million$172.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2015Q115$0.21$0.21$104.20 million$113.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2015Q414$0.23$0.27$95.50 million$103.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314$0.17$0.24$73.17 million$75.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214$0.10$0.21$58.35 million$66.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2014Q114$0.01$0.16$42.69 million$51.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2014Q413($0.08)($0.22)$32.20 million$43.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2013Q3 13($0.25)($0.03)$18.31 million$31.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2013Q213($0.32)($0.24)$16.09 million$17.64 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/10/2013Q113($0.35)($0.30)$9.47 million$9.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2012Q312($0.68)($0.39)$4.12 million$7.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Horizon Pharma PLC (NASDAQ:HZNP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.58$0.58$0.58
Q2 20161$0.49$0.49$0.49
Q3 20161$0.70$0.70$0.70
Q4 20161$0.85$0.85$0.85
(Data provided by Zacks Investment Research)
Dividend History for Horizon Pharma PLC (NASDAQ:HZNP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Horizon Pharma PLC (NASDAQ:HZNP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/15/2016Virinder NohriaDirectorSell25,000$17.69$442,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2016Jeffrey W ShermanEVPSell4,100$20.00$82,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Jeffrey W ShermanEVPSell4,456$20.00$89,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/21/2015Jeffrey W ShermanEVPSell7,750$31.78$246,295.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Jeffrey W ShermanEVPSell26,887$35.55$955,832.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Jeff HimawanDirectorSell554,564$22.44$12,444,416.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Jeff HimawanDirectorSell1,614,827$21.85$35,283,969.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Jeff HimawanDirectorSell3,450,000$12.05$41,572,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Jeffrey W ShermanEVPSell24,999$12.05$301,237.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Timothy P WalbertCEOSell150,000$12.05$1,807,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Balaji VenkataramanMajor ShareholderSell6,086,957$11.54$70,243,483.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Virinder NohriaDirectorSell1,739,130$11.54$20,069,560.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014Vaere Robert J DeCFOSell51,942$12.28$637,847.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Timothy WalbertCEOSell31,742$12.94$410,741.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Todd SmithEVPSell10,159$12.94$131,457.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Vaere Robert DeCFOSell12,939$12.94$167,430.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/13/2013Jeffrey BirdDirectorBuy668,673$6.50$4,346,374.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013Timothy WalbertCEOSell12,124$6.79$82,321.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013Todd SmithEVPSell11,322$6.91$78,235.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2013Jeffrey BirdDirectorBuy151,089$6.24$942,795.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2012Jeffrey W BirdDirectorBuy575,356$3.49$2,007,992.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Horizon Pharma PLC (NASDAQ:HZNP)
DateHeadline
06/24/16 07:09 AMHorizon Pharma plc (NASDAQ:HZNP) Earnings Glance and Target Price Review - Engelwood Daily
06/24/16 07:09 AMHorizon Pharma plc (NASDAQ:HZNP) Analyst Rating Update - Investor Newswire
06/24/16 07:09 AMBroadfin Capital LLC Increased Horizon Pharma Plc (NASDAQ:HZNP) by $101.17 Million as Shares Declined - Press Telegraph
06/24/16 07:09 AMHC Stocks Analysis: Horizon Pharma PLC (NASDAQ:HZNP), Prima BioMed Ltd (ADR) (NASDAQ:PBMD) - share market updates (press release)
06/23/16 07:27 AMHC Stocks in the Rumor: Bristol-Myers Squibb Co (NYSE:BMY), Horizon Pharma PLC (NASDAQ:HZNP) - share market updates (press release)
06/23/16 07:27 AMHorizon Pharma plc (NASDAQ:HZNP) Analyst Rating Consensus - Trade Calls
06/21/16 04:16 PMRecent research into Overt Hepatic Encephalopathy report for 2016 just published
06/15/16 04:37 PMAnalyst Overview: Lincoln National Corporation (NYSE:LNC), Horizon Pharma plc (NASDAQ:HZNP) - Beacon Chronicle
06/15/16 09:10 AMNoteworthy Analyst's Rating to Observe: CVS Health Corporation (NYSE:CVS) , Horizon Pharma plc (NASDAQ:HZNP) - Street Updates
06/14/16 09:20 AMRecent Analysts Moves of Stocks: Rock Creek Pharmaceuticals, (RCPI) , Horizon Pharma (HZNP) - Street Updates
06/14/16 09:20 AMAnalysts Tips to Monitor: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Horizon Pharma plc (NASDAQ:HZNP) - Street Updates
06/13/16 07:19 AMRevenue Estimates for Investors: Horizon Pharma plc (NASDAQ:HZNP) - News Oracle
06/13/16 07:19 AMComprehensive Report on: Horizon Pharma plc (NASDAQ:HZNP), Mobileye N.V. (NYSE:MBLY) - Beacon Chronicle
06/10/16 04:42 PMUpdated Analysts Rating Report: MannKind Corporation (NASDAQ:MNKD) , Horizon Pharma plc (NASDAQ:HZNP) - Street Updates
06/10/16 08:52 AMIs Horizon Pharma's Rebound Sustainable? - Has Horizon turned the corner after a rough start to 2016?
06/10/16 07:17 AMTrending Analyst Recommended Stock: Horizon Pharma plc (NASDAQ:HZNP) - News Oracle
06/10/16 07:17 AMEarnings Estimates Highlight: Horizon Pharma plc (NASDAQ:HZNP), Prudential Financial, Inc. (NYSE:PRU) - Beacon Chronicle
06/09/16 04:41 PMAnalyst Suggestions update: Horizon Pharma plc (NASDAQ:HZNP), Zions Bancorporation (NASDAQ:ZION) - Beacon Chronicle
06/09/16 07:13 AMAnalysts Suggestion Alert: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) , Horizon Pharma plc (NASDAQ:HZNP) - Street Updates
06/08/16 04:50 PMHORIZON PHARMA PLC (NASDAQ:HZNP) Financial Condition Compared to S&P 500 - CML News
06/08/16 07:17 AMHC Stocks Indications: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Horizon Pharma PLC (NASDAQ:HZNP) - share market updates (press release)
06/08/16 07:17 AMStock's Earnings Activity: Horizon Pharma plc (NASDAQ:HZNP), Precision Drilling Corporation (NYSE:PDS) - Beacon Chronicle
06/07/16 04:43 PMHC Stocks Reports: Adamis Pharmaceuticals Corp (NASDAQ:ADMP), Horizon Pharma PLC (NASDAQ:HZNP) - share market updates (press release)
06/07/16 04:43 PMHorizon Pharma plc (HZNP) Jumps 5.67% on June 06 - Equities.com
06/07/16 02:42 PMNuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting - [CNW Group] - Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting
06/06/16 04:27 PMAnalyst Recommended Stock: Horizon Pharma (HZNP) - News Oracle
06/06/16 08:06 AMHorizon Pharma PLC (HZNP) Now Covered by Analysts at Goldman Sachs - Let Me Know About This
06/03/16 04:52 PMSummary of Analyst's Study: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Horizon Pharma plc (NASDAQ:HZNP) - Street Updates
06/03/16 04:52 PMHas Horizon Pharma Bottomed? - Seeking Alpha
06/03/16 06:17 AMSell Alert: These 5 Stocks Look Toxic Right Now -
06/02/16 04:47 PMStocks with Buy Signals: Horizon Pharma plc (NASDAQ:HZNP), CBS Corporation (NYSE:CBS) - Beacon Chronicle - Beacon ChronicleStocks with Buy Signals: Horizon Pharma plc (NASDAQ:HZNP), CBS Corporation (NYSE:CBS)Beacon ChronicleLast Trade: The Company closed its last session at $17.5 with the gain of 1.57%. The market capitalization of the company is $2.76 Billion, with the average Volume of 5.07 Million. The stock currently has its 52-Week High range of $39.49 and 52-week ...and more »
06/02/16 07:18 AMHorizon Pharma (HZNP) Receives USPTO Notice of Allowance on Patent Related to VIMOVO - StreetInsider.com - Horizon Pharma (HZNP) Receives USPTO Notice of Allowance on Patent Related to VIMOVOStreetInsider.comHorizon Pharma plc (Nasdaq: HZNP) announced the issuance of a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number 14/980,639, entitled "Method for Delivering a Pharmaceutical ...Horizon Pharma Issued Notice of Allowance From U.S.P.T.O. For Vimovo (NASDAQ:HZNP)Sonoran Weekly ReviewHorizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance ...Marketwired (press release)Health Care Sector Update for 06/01/2016: HZNP, TBPHNasdaqall 3 news articles »
06/02/16 07:18 AMHorizon Pharma PLC (HZNP) Now Covered by Analysts at Citigroup Inc. - Let Me Know About This - Horizon Pharma PLC (HZNP) Now Covered by Analysts at Citigroup Inc.Let Me Know About ThisHorizon Pharma PLC logo Equities research analysts at Citigroup Inc. began coverage on shares of Horizon Pharma PLC (NASDAQ:HZNP) in a research report issued to clients and investors on Wednesday, StockTargetPrices.com reports. The firm set a ...HC Stocks Movements to Focus: Merck & Co., Inc. (NYSE:MRK), Horizon Pharma PLC (NASDAQ:HZNP)share market updates (press release)all 4 news articles »
06/02/16 06:25 AMHorizon Pharma plc to Participate in Jefferies 2016 Healthcare Conference - [at noodls] - DUBLIN, IRELAND -- (Marketwired) -- 06/02/16 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing ...
06/01/16 04:51 PMAnalyst Recommended Stocks: Horizon Pharma plc (NASDAQ:HZNP), Fidelity National Information Services, Inc ... - Beacon Chronicle - Analyst Recommended Stocks: Horizon Pharma plc (NASDAQ:HZNP), Fidelity National Information Services, Inc ...Beacon ChronicleHorizon Pharma plc (NASDAQ:HZNP) currently has High Price Target of $45. The Low and Mean Price Targets are $18 and $30.91 respectively. These price targets are a consensus analysis of 11 brokers. When having a look at Recommendation Trends of ...and more »
06/01/16 07:17 AMNews Sentiment For Horizon Pharma plc (NASDAQ:HZNP) - Investor Newswire - News Sentiment For Horizon Pharma plc (NASDAQ:HZNP)Investor NewswireHorizon Pharma plc (NASDAQ:HZNP) Average broker stands at 1.47 while it was 1.47 three months ago. The quarterly report of Horizon Pharma plc (NASDAQ:HZNP) can be made public close to 2016-08-05. It is estimated by the recent update released by ...and more »
06/01/16 07:17 AMHC Stocks Summary: Horizon Pharma PLC (NASDAQ:HZNP), Galena Biopharma Inc (NASDAQ:GALE) - share market updates (press release) - share market updates (press release)HC Stocks Summary: Horizon Pharma PLC (NASDAQ:HZNP), Galena Biopharma Inc (NASDAQ:GALE)share market updates (press release)Shares of Horizon Pharma PLC (NASDAQ:HZNP) ended Tuesday session in green amid volatile trading. The shares closed up +0.63 points or 3.80% at $17.23 with 3.22 million shares getting traded. Post opening the session at $16.69, the shares hit an ...and more »
06/01/16 06:13 AMHorizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets - [at noodls] - DUBLIN, IRELAND -- (Marketwired) -- 06/01/16 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing ...
05/31/16 05:55 AMHorizon Pharma PLC (NASDAQ:HZNP) & Las Vegas Sands Corp. (NYSE:LVS) Stocks Alert - Wall Street 24 - Horizon Pharma PLC (NASDAQ:HZNP) & Las Vegas Sands Corp. (NYSE:LVS) Stocks AlertWall Street 24On Friday, Shares of Horizon Pharma PLC (NASDAQ:HZNP) gained 1.72% to $16.60. The share price is trading in a range of $16.31 – $16.79. The stock exchanged hands with 2.14 Million shares contrast to its average daily volume of 4.44 Million shares.and more »
05/30/16 04:13 PMStrong Sell Calls Count For Horizon Pharma plc (NASDAQ:HZNP) At 1 - RealistInvestor.com - Strong Sell Calls Count For Horizon Pharma plc (NASDAQ:HZNP) At 1RealistInvestor.comBuy calls count on Horizon Pharma plc (NASDAQ:HZNP) stock stands at 0 and Sell recommendations is 0 while hold recommendations is 0. Horizon Pharma plc (NASDAQ:HZNP) has a total of 6 Strong Buy calls and 1 Strong Sell advises as of 2016-05-29.and more »
05/28/16 02:40 AMEarnings Review and Stock Rundown for Horizon Pharma plc (NASDAQ:HZNP) - Wall Street Hints and News - Earnings Review and Stock Rundown for Horizon Pharma plc (NASDAQ:HZNP)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Horizon Pharma plc (NASDAQ:HZNP) to post ...and more »
05/27/16 04:27 PMHC Stocks in the Rumor: Horizon Pharma PLC (NASDAQ:HZNP), Medivation Inc (NASDAQ:MDVN) - share market updates (press release) - NYSE Journal (press release)HC Stocks in the Rumor: Horizon Pharma PLC (NASDAQ:HZNP), Medivation Inc (NASDAQ:MDVN)share market updates (press release)Shares of Horizon Pharma PLC (NASDAQ:HZNP) ended Thursday session in green amid volatile trading. The shares closed up +0.16 points or 0.99% at $16.32 with 3.01 million shares getting traded. Post opening the session at $16.21, the shares hit an ...Intraday Movers: Horizon Pharma PLC (NASDAQ:HZNP), United Continental Holdings Inc (NYSE:UAL)NYSE Journal (press release)all 2 news articles »
05/27/16 07:05 AMAnalyst Rating Fluctuations to Observe: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Horizon Pharma plc (NASDAQ ... - Street Updates - Analyst Rating Fluctuations to Observe: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Horizon Pharma plc (NASDAQ ...Street UpdatesHorizon Pharma plc (NASDAQ:HZNP) showed bullish move with gain of +0.99% after exchanging volume of 3.01 million shares in last trading session ended on 5/26/2016. The company recent traded volume was lower than its average volume of 5.33 million ...and more »
05/26/16 04:15 PMHealthcare Movers to Observe: Horizon Pharma plc (NASDAQ:HZNP) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Is stories - Is storiesHealthcare Movers to Observe: Horizon Pharma plc (NASDAQ:HZNP) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Is storiesHorizon Pharma plc (NASDAQ:HZNP) increased +4.66% to $16.16 while traded 4.78 million shares on 5/25/2016. The stock price negotiated for value between $15.35 to $16.20 in recent trading session. During the past 52 weeks, the stock's price witnessed ...Stocks Analysts Ranking Summary: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) , Horizon Pharma plc (NASDAQ:HZNP)Street Updatesall 29 news articles »
05/26/16 07:20 AMDeerfield Management Company Increased Horizon Pharma Plc (NASDAQ:HZNP) by $32.89 Million as Shares Declined - CCH Daily News - Deerfield Management Company Increased Horizon Pharma Plc (NASDAQ:HZNP) by $32.89 Million as Shares DeclinedCCH Daily NewsJames E. Flynn increased its stake in Horizon Pharma Plc (NASDAQ:HZNP) by 17.59% based on its latest 2016Q1 regulatory filing with the SEC. Deerfield Management Company bought 2.06 million shares as the company's stock declined 21.36% while ...and more »
05/26/16 07:20 AMAnalysts Ranking Activities: Horizon Pharma plc (NASDAQ:HZNP) , UnitedHealth Group Incorporated (NYSE:UNH) - Street Updates - Analysts Ranking Activities: Horizon Pharma plc (NASDAQ:HZNP) , UnitedHealth Group Incorporated (NYSE:UNH)Street UpdatesHorizon Pharma plc (NASDAQ:HZNP) accumulated +4.66%, closing at $16.16 after floating between $15.35 and $16.20. The company has market capitalization of $2.59B. It has twelve month low of $12.86 and twelve month high of $39.49. The recent traded ...and more »
05/26/16 07:19 AMHorizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : May 26, 2016 -
05/25/16 04:02 PMBroadfin Capital LLC Increased Horizon Pharma Plc (NASDAQ:HZNP) by $101.17 Million as Shares Declined - CCH Daily News - Broadfin Capital LLC Increased Horizon Pharma Plc (NASDAQ:HZNP) by $101.17 Million as Shares DeclinedCCH Daily NewsKevin Kotler increased its stake in Horizon Pharma Plc (NASDAQ:HZNP) by 1264.68% based on its latest 2016Q1 regulatory filing with the SEC. Broadfin Capital Llc bought 6.32 million shares as the company's stock declined 21.36% while stock markets ...and more »
05/25/16 04:02 PMHC Trending Stocks: Horizon Pharma PLC (NASDAQ:HZNP), ImmunoGen, Inc. (NASDAQ:IMGN) - share market updates (press release) - share market updates (press release)HC Trending Stocks: Horizon Pharma PLC (NASDAQ:HZNP), ImmunoGen, Inc. (NASDAQ:IMGN)share market updates (press release)Shares of Horizon Pharma PLC (NASDAQ:HZNP) ended Tuesday session in green amid volatile trading. The shares closed up +0.14 points or 0.92% at $15.44 with 2.52 million shares getting traded. Post opening the session at $15.45, the shares hit an ...and more »
05/25/16 02:02 PMBiotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well -
About Horizon Pharma PLC

Horizon Pharma PLC logoHorizon Pharma plc, formerly Vidara Therapeutics International Public Limited Company, is a specialty biopharmaceutical company focused on identifying, developing, acquiring or in-licensing and commercializing differentiated products that address unmet medical needs. The Company markets a portfolio of products in arthritis, inflammation and orphan diseases. The Company's the United States marketed products are ACTIMMUNE (interferon gamma-1b), DUEXIS (ibuprofen/famotidine), PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%), RAYOS (prednisone) delayed-release tablets and VIMOVO (naproxen/esomeprazole magnesium). The Company developed DUEXIS and RAYOS/LODOTRA, has the United States rights to VIMOVO, has the United States rights to ACTIMMUNE and has the United States rights to PENNSAID 2%.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: HZNP
  • CUSIP: 44047T10
Key Metrics:
  • Previous Close: $16.25
  • 50 Day Moving Average: $16.33
  • 200 Day Moving Average: $17.39
  • P/E Ratio: 211.04
  • P/E Growth: 0.56
  • Market Cap: $2.61B
  • Current Quarter EPS Consensus Estimate: $2.34 EPS
Additional Links:
Horizon Pharma PLC (NASDAQ:HZNP) Chart for Friday, June, 24, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha